| |
 |
|
Class Information
Number: 514/178
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system > Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system
Description: Subject matter wherein one nuclear carbon of the cyclopentanohydrophenanthrene nucleus is bonded to an oxygen through a double bond and wherein another nuclear carbon atom of said cyclopentanohydrophenanthrene is bonded to at least one other oxygen through a single bond as, e.g., ether, hydroxy or alcoholate, etc.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6670350 |
Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same |
Dec. 30, 2003 |
| 6670349 |
Composition & method for altering levels of or sensitivity to adenosine with a dehydroepiandrosterone &/or a ubiquinone |
Dec. 30, 2003 |
| 6667299 |
Pharmaceutical compositions and treatment methods |
Dec. 23, 2003 |
| 6667026 |
Allergic contact dermatitis treatment and composition therefor |
Dec. 23, 2003 |
| 6660726 |
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
Dec. 9, 2003 |
| 6656970 |
Method and compositions for solubilization of pentacyclic triterpenes |
Dec. 2, 2003 |
| 6656505 |
Method for forming an aqueous flocculated suspension |
Dec. 2, 2003 |
| 6653297 |
Control of selective estrogen receptor modulators |
Nov. 25, 2003 |
| 6645954 |
Compositions comprising ethisterone or its derivatives |
Nov. 11, 2003 |
| 6645953 |
Meiosis regulating compounds |
Nov. 11, 2003 |
| 6642236 |
Methods for prophylactic treatment of cardiovascular disease with inhibitor of cortisol synthesis |
Nov. 4, 2003 |
| 6641800 |
Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane |
Nov. 4, 2003 |
| 6642219 |
Progestogen-antiprogestogen regimens |
Nov. 4, 2003 |
| 6620802 |
Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist |
Sep. 16, 2003 |
| 6620803 |
Cosmetic or dermatological use of 7-hydroxylated steroids |
Sep. 16, 2003 |
| 6613758 |
Method for treating osteoporosis in castrated prostatic cancer patients |
Sep. 2, 2003 |
| 6610675 |
Inactive metabolite approach to soft drug design |
Aug. 26, 2003 |
| 6610674 |
Method of treating inflammatory conditions with progesterone analogs |
Aug. 26, 2003 |
| 6610676 |
Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
Aug. 26, 2003 |
| 6605605 |
Estrogenic substances combined with cruciferous indole compounds |
Aug. 12, 2003 |
| 6605591 |
Treatment of subnormal bone mineral density |
Aug. 12, 2003 |
| 6593320 |
Flocculated suspension of megestrol acetate |
Jul. 15, 2003 |
| 6593316 |
Use of .DELTA.5-androstene-3.beta.ol-7,17-dione in the treatment of lupus erythematosus |
Jul. 15, 2003 |
| 6593318 |
Flocculated suspension of megestrol acetate |
Jul. 15, 2003 |
| 6593319 |
Fusidic acid derivatives |
Jul. 15, 2003 |
| 6589945 |
Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
Jul. 8, 2003 |
| 6586417 |
Ester and ether derivatives of 4-hydroxy 4-androstene-3,17-dione and a method for the regulation of athletic function in humans |
Jul. 1, 2003 |
| 6583129 |
Administration of non-oral androgenic steroids to women |
Jun. 24, 2003 |
| 6579863 |
Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
Jun. 17, 2003 |
| 6579864 |
3-methylene steroid derivatives |
Jun. 17, 2003 |
| 6569844 |
Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives |
May. 27, 2003 |
| 6569845 |
Neovascularization inhibitor containing dienogest as the active ingredient |
May. 27, 2003 |
| 6562790 |
Hormone therapy methods and hormone products for abating coronary artery blockage |
May. 13, 2003 |
| 6555530 |
Use of estrogens and delta-gonadien-21-Ol-3,20-diones for treating insulin dependent and non-insulin dependent diabetes |
Apr. 29, 2003 |
| 6548087 |
Nutritional supplement |
Apr. 15, 2003 |
| 6544550 |
Medicaments for gastrointestinal disorders |
Apr. 8, 2003 |
| 6544971 |
Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices |
Apr. 8, 2003 |
| 6541465 |
Orally active androgens |
Apr. 1, 2003 |
| 6531461 |
Medicament for the treatment of diabetes |
Mar. 11, 2003 |
| 6524623 |
Therapeutic compositions and methods of use thereof |
Feb. 25, 2003 |
| 6525039 |
B-ring estratrienes |
Feb. 25, 2003 |
| 6514516 |
Formulations and methods for providing prolonged local anesthesia |
Feb. 4, 2003 |
| 6514980 |
Nucleoside analogs in combination therapy of herpes simplex infections |
Feb. 4, 2003 |
| 6511970 |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
Jan. 28, 2003 |
| 6506742 |
Soluble contraceptive liquid formulation |
Jan. 14, 2003 |
| 6503894 |
Pharmaceutical composition and method for treating hypogonadism |
Jan. 7, 2003 |
| 6498153 |
Extended release growth promoting two component composition |
Dec. 24, 2002 |
| 6495534 |
Stabilized aqueous suspensions for parenteral use |
Dec. 17, 2002 |
| 6489313 |
Memory by the administration of .DELTA.5-androstene-3.beta.-ol-7,17-dione and 3.beta. esters |
Dec. 3, 2002 |
| 6486147 |
Cosmetic composition containing a steroid and a 2-alkylalkanol or an ester thereof |
Nov. 26, 2002 |
|
|
|
